C7ORF44 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.495960E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.270790E-01
Normal-vs-Stage2
1.841400E-01
Normal-vs-Stage3
4.646800E-01
Normal-vs-Stage4
3.311600E-01
Stage1-vs-Stage2
8.568600E-01
Stage1-vs-Stage3
9.181800E-01
Stage1-vs-Stage4
9.705400E-01
Stage2-vs-Stage3
9.882200E-01
Stage2-vs-Stage4
8.546800E-01
Stage3-vs-Stage4
9.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.603180E-01
Normal-vs-AfricanAmerican
1.180600E-01
Normal-vs-Asian
3.410400E-01
Caucasian-vs-AfricanAmerican
7.223400E-01
Caucasian-vs-Asian
8.067400E-01
AfricanAmerican-vs-Asian
6.712400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.316560E-01
Normal-vs-Female
1.956970E-01
Male-vs-Female
3.330400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.524200E-01
Normal-vs-Age(41-60Yrs)
4.208400E-01
Normal-vs-Age(61-80Yrs)
6.384100E-02
Normal-vs-Age(81-100Yrs)
3.469400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.224400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.989400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
7.665800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.218610E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.705800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.450400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.529760E-01
Normal-vs-Daily Drinker
2.877200E-01
Normal-vs-Weekly Drinker
3.699600E-01
Normal-vs-Occasional Drinker
2.775800E-01
Normal-vs-Social Drinker
3.806400E-01
Non Drinker-vs-Daily Drinker
6.394600E-01
Non Drinker-vs-Weekly Drinker
5.771400E-01
Non Drinker-vs-Occasional Drinker
4.982400E-01
Non Drinker-vs-Social Drinker
5.027600E-01
Daily Drinker-vs-Weekly Drinker
8.910200E-01
Daily Drinker-vs-Occasional Drinker
8.544600E-01
Daily Drinker-vs-Social Drinker
8.210600E-01
Weekly Drinker-vs-Occasional Drinker
9.839000E-01
Weekly Drinker-vs-Social Drinker
9.410600E-01
Occasional Drinker-vs-Social Drinker
9.470000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.335400E-01
Normal-vs-Grade 2
9.558600E-01
Normal-vs-Grade 3
9.810200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.394000E-01
Grade 1-vs-Grade 3
1.820440E-01
Grade 1-vs-Grade 4
9.335400E-01
Grade 2-vs-Grade 3
1.673990E-01
Grade 2-vs-Grade 4
9.558600E-01
Grade 3-vs-Grade 4
9.810200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.455900E-02
Normal-vs-NonDiabetic
2.168000E-01
Diabetic-vs-NonDiabetic
7.179900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.375800E-01
Normal-vs-NoPancreatitis
1.400610E-01
Pancreatitis-vs-NoPancreatitis
2.584600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.010400E-02
Normal-vs-N1
1.991210E-01
N0-vs-N1
5.411400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.449400E-01
Normal-vs-TP53-NonMutant
2.422800E-01
TP53-Mutant-vs-TP53-NonMutant
1.414380E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
